James W. Murrough - Concepedia

Author

James W. Murrough

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

J W Murrough, J. Murrough, J. W. Murrough, J.W. Murrough, JW Murrough, James Murrough, James W Murrough, James W. Murrough, Oneysha Brown

278

Publications

21.8K

Citations

H-Index

105

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Allen Institute for Brain Science Yale University Center for Discovery Baylor College of Medicine

About

James W. Murrough is an author at Icahn School of Medicine at Mount Sinai specializing in psychiatry, medicine, and depression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	51	7.3K
2	Social Sciences	31	42	6.2K
3	Health Sciences	3	3	798
4	Public Health	2	2	46
5	Nursing	1	1	10

James W. Murrough

106

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial James W. Murrough, Dan V. Iosifescu, Lee C. Chang, American Journal of Psychiatry	2013	1.2K
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression James W. Murrough, Andrew M. Perez, Sarah Pillemer, Biological Psychiatry PsychiatryMood SymptomPsychotropic MedicationPharmacologyDepression	2012	766
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress Georgia E. Hodes, Madeline L. Pfau, Marylène Leboeuf, Proceedings of the National Academy of Sciences	2014	684
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression Marije aan het Rot, Katherine A. Collins, James W. Murrough, Biological Psychiatry PsychiatryMedicinePsychotropic MedicationPsychopharmacologyDepression	2009	682
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study Ahmed Tawakol, Amorina Ishai, Richard A. P. Takx, The Lancet Amygdalar ActivityPsychiatryMood SymptomPsychophysiologySubcortical Ischemic Depression	2017	603
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Adriana Feder, Michael K. Parides, James W. Murrough, JAMA Psychiatry	2014	589
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, World Psychiatry PsychotherapyElectroconvulsive TherapyMental HealthDrug TreatmentTreatment-resistant Depression	2023	556
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression Jaskaran Singh, Maggie Fedgchin, Ella Daly, American Journal of Psychiatry	2016	511
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder Kyle Lapidus, Cara F. Levitch, Andrew M. Perez, Biological Psychiatry PsychiatryPsychotropic MedicationDepressionPsychopharmacologyNeuropharmacology	2014	474
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) Maurizio Fava, Marlene P. Freeman, Martina Flynn, Molecular Psychiatry PsychiatryMood SymptomMedicinePsychotropic MedicationDepression	2018	421

Page 1